Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18675181rdf:typepubmed:Citationlld:pubmed
pubmed-article:18675181lifeskim:mentionsumls-concept:C0019196lld:lifeskim
pubmed-article:18675181lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:18675181lifeskim:mentionsumls-concept:C1623038lld:lifeskim
pubmed-article:18675181pubmed:issue3 Pt 2lld:pubmed
pubmed-article:18675181pubmed:dateCreated2008-8-4lld:pubmed
pubmed-article:18675181pubmed:abstractTextThe screening for the detection of hepatocellular carcinoma is based on ultrasound sonography which should be realised in patients with post-hepatitis C cirrhosis with a delay between 3 and 6 months according to the most identified risk factors, in particular age and sex male. In the case of discovery of hypoechogen nodule < or = 1cm, a follow-up is mandatory because it is usually untypical by ultrasound sonography and to propose a liver biopsy in the case of an increasing in size is shown. The ultrasound guided cutting biopsy can precise the histological characteristics of the nodule, the grade, and indicate prognostic factors. The liver biopsy is also mandatory in the case of a nodule > 2 cm and when the ultrasound sonography is not contributive, especially when the nodule is between 1 and 2 cm in size.lld:pubmed
pubmed-article:18675181pubmed:languagefrelld:pubmed
pubmed-article:18675181pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18675181pubmed:citationSubsetIMlld:pubmed
pubmed-article:18675181pubmed:statusMEDLINElld:pubmed
pubmed-article:18675181pubmed:monthMarlld:pubmed
pubmed-article:18675181pubmed:issn0399-8320lld:pubmed
pubmed-article:18675181pubmed:authorpubmed-author:SamuelDDlld:pubmed
pubmed-article:18675181pubmed:authorpubmed-author:FilocheBBlld:pubmed
pubmed-article:18675181pubmed:authorpubmed-author:DoffoelMMlld:pubmed
pubmed-article:18675181pubmed:authorpubmed-author:MarcellinPPlld:pubmed
pubmed-article:18675181pubmed:authorpubmed-author:BedossaPPlld:pubmed
pubmed-article:18675181pubmed:authorpubmed-author:ZarskiJ-PJPlld:pubmed
pubmed-article:18675181pubmed:issnTypePrintlld:pubmed
pubmed-article:18675181pubmed:volume32lld:pubmed
pubmed-article:18675181pubmed:ownerNLMlld:pubmed
pubmed-article:18675181pubmed:authorsCompleteYlld:pubmed
pubmed-article:18675181pubmed:paginationS117-20lld:pubmed
pubmed-article:18675181pubmed:dateRevised2010-8-17lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:meshHeadingpubmed-meshheading:18675181...lld:pubmed
pubmed-article:18675181pubmed:year2008lld:pubmed
pubmed-article:18675181pubmed:articleTitle[Hepatitis C, cirrhosis and hepatocellular carcinoma].lld:pubmed
pubmed-article:18675181pubmed:affiliationClinique Universitaire d'Hépato-Gastroentérologie, Pôle DIGI-DUNE, Centre de recherche INSERM/UJF U823 IAPC Institut Albert Bonniot, CHU de Grenoble BP 217, 38043 Grenoble cedex, France. JPZarski@chu-grenoble.frlld:pubmed
pubmed-article:18675181pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18675181pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:18675181pubmed:publicationTypeReviewlld:pubmed